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and major depression); and psychosis (operationally defined 
by the occurrence of at least 1 episode of hallucinations and/
or delusions).  Results and Conclusion: For BPI only, the most 
interesting result was obtained for chromosome 7p21.1–
p22.2 under a recessive model of inheritance (heterogeneity 
LOD score = 2.80), a region that had previously been linked 
to BP in a study on Portuguese Island families. For both BPI 
and mood disorders, nonparametric analyses identified a lo-
cus on chromosome 12ct–q14 (nonparametric linkage = 2.55 
and 2.35, respectively). This locus has not previously been 
reported as a candidate region for BP. Additional candidate 
regions were found on chromosomes 1p22–31 (mood disor-
ders) and 21q21–22 (BPI), 2 loci that have repeatedly been 
implicated in BP susceptibility. Linkage analysis of psychosis 
as a phenotype identified candidate regions on chromo-
somes 2q24–31 and 16p12–q12. The finding on chromosome 
16p is noteworthy because the same locus has been impli-
cated by genome-wide association analyses of BP. 
 Copyright © 2010 S. Karger AG, Basel 
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 Abstract 
 Background/Aims: Bipolar disorder (BP) is a severe psychi-
atric illness, characterised by alternating episodes of depres-
sion and mania, which ranks among the top ten causes of 
morbidity and life-long disability world-wide. We have pre-
viously performed a whole-genome linkage scan on 6 pedi-
grees segregating severe BP from the well-characterised 
population isolate of Antioquia, Colombia. We recently col-
lected genotypes for the same set of 382 autosomal micro-
satellite markers in 9 additional Antioquian BP pedigrees. 
Here, we report the analysis of the combined pedigree set. 
 Methods: Linkage analysis using both parametric and non-
parametric approaches was conducted for 3 different diag-
nostic models: severe BP only (BPI); mood disorders (BPI, BPII 
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 Introduction 
 Bipolar disorder (BP) is a severe and complex psychi-
atric condition characterised by alternating episodes of 
depression and mania  [1] . Based on clinical severity, 2 
variants of this disorder are commonly distinguished: BP 
type I (BPI), including at least 1 episode of full-blown ma-
nia, typically requiring hospitalization, and BP type II 
(BPII), characterised by hypomanic episodes, represent-
ing a milder form of mania  [1] . With a life-time preva-
lence of 1–1.5% across populations and genders  [2] , BP is 
among the top ten causes of morbidity and life-long dis-
ability in both the developing and the developed world 
 [3] . Family, twin and adoption studies provide strong ev-
idence for a genetic contribution to the aetiology of this 
disorder  [4, 5] ; however, progress in the identification of 
disease-causing variants has been slow. Family-based 
linkage studies have produced inconsistent results, and 
the first genome-wide association scans (GWAS) in BP 
have failed to live up to the expectations generated by the 
GWAS findings in other complex diseases  [6, 7] . These 
disappointing results are most likely related to the genet-
ic heterogeneity and phenotypic variability resulting 
from the descriptive nature of psychiatric diagnoses. The 
study of a rigorously phenotyped pedigree collection 
from a population isolate should help reduce this pheno-
typic and genetic heterogeneity. We have previously im-
plemented this approach by carrying out a whole-genome 
linkage scan in 6 extended pedigrees segregating severe 
BP from a well-characterised population isolate (Antio-
quia in Colombia)  [8, 9] , and found genome-wide signif-
icant evidence of linkage on chromosome 5q31–34  [10] . 
This signal has subsequently been confirmed through 
fine-mapping of pedigrees and trios from both Antioquia 
and the related isolate of the Central Valley of Costa Rica 
 [10, 11] .
 Since reporting the results of this initial linkage scan, 
we have collected genome-wide linkage data for 9 addi-
tional Antioquian BP families. Here, we report the results 
of the joint analysis of our original linkage data  [10] and 
the data for these additional pedigrees. In these extended 
analyses we also explore additional diagnostic and ge-
netic models.
 Subjects and Methods 
 Subjects 
 Fifteen extended pedigrees segregating severe BP were collect-
ed as part of an ongoing psychiatric genetics programme in the 
population isolate of Antioquia, Colombia ( fig. 1 ). Six of these had 
been included in a previous linkage scan (CO3, CO4, CO7, CO14, 
CO18, CO27;  fig. 1 b)  [10] . Index cases were recruited in the mu-
nicipalities of Medellín and Envigado (Antioquia, Colombia) at 
the Hospital Mental de Antioquia, the Hospital San Vicente de 
Paúl, the Clínica Sameín, the Clínica Insam, and the Mental 
Health Centre of Envigado. All index cases had at least 6 great-
grandparents born in Antioquia. Families with at least 3 individ-
uals with a clinical diagnosis of BP were chosen for pedigree ex-
tension by a social worker or psychiatric nurse using the Family 
Interview for Genetic Studies  [12] . Family CO24 includes only 2 
cases of BP; it was studied because it also includes 1 case of major 
depression and 1 case of schizophrenia, which are phenotypes 
also considered in the analyses (see below).
 Family members were assessed by a psychiatrist using the 
Spanish version of the Diagnostic Interview for Genetic Studies 
(DIGS version 3) that we validated in Colombia  [12, 13] . Final 
DSM-IV-TR diagnoses  [14] were reached through consensus be-
tween 2 expert psychiatrists in a best estimate procedure, as de-
scribed by Freimer and colleagues  [15] . The occurrence of psy-
chotic episodes was determined based on both the DIGS and med-
ical records. Family members with a clinical diagnosis of BPI who 
were unavailable for interview (including deceased individuals) 
were considered affected if they had undergone at least 2 hospital-
izations and clinical records allowed confirmation of symptoms 
through the best estimate process. No psychiatric diagnoses oth-
er than BPI were considered in family members that were unavail-
able for interview. In order to maintain a strict phenotypic defini-
tion, and to rule out cases where psychiatric symptoms might be 
secondary to other medical conditions, any psychiatric diagnoses 
in patients with mental retardation and/or neurological lesions, 
as well as cases related to substance abuse, were disregarded for 
the analyses. Altogether, the sample comprised 90 cases of BPI 
(37.8% males, 62.2% females; age at onset 22.2  8 7.6 years), 22 
cases of major depression (18.2% males, 82.8% females; age at on-
set 26.6  8 13.8 years), and 1 case each of schizophrenia (female; 
age at onset 27 years) and BPII (male; age at onset could not be 
determined reliably). A total of 46 individuals (30.4% males, 
69.6% females) had suffered from psychosis, operationally de-
fined by the occurrence of at least 1 episode of hallucinations and/
or delusions. These included 43 of the 90 BPI cases (47.8%), the 
schizophrenic individual and 2 individuals with a psychotic 
mood disorder that did not meet the full diagnostic criteria for BP 
(these 2 individuals are included in families CO14 and CO15; see 
 fig. 1 ). Written informed consent was obtained from all subjects 
prior to enrolment in the study. This research was approved by the 
Ethics Committees of all participating institutions.
 Genotyping 
 DNA was extracted from whole blood using standard labora-
tory procedures. Genotype data for 9 newly ascertained pedigrees 
from Antioquia were obtained for 382 evenly spaced autosomal 
microsatellite markers from the ABI Linkage Mapping Set v2.5 
(Applied Biosystems, Warrington, UK; average distance   10 cM). 
Fragment length analysis was performed on a 96-capillary 3730 xl 
DNA Analyzer (Applied Biosystems), and raw genotyping data 
were analysed using the GeneMapper  software v3.7 (Applied 
Biosystems). Genotypes were scored independently by 2 research-
ers blinded to affection status and relatedness between subjects 
(‘double scoring’). Any discordant genotypes were disregarded 
and, if necessary, repeated. Genotype data were checked for in-
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 Fig. 1.  a Set of 9 Antioquian pedigrees segregating severe BP ge-
notyped for this study. Individuals marked with a cross were 
available for genotyping. Both sets of pedigrees (shown here and 
in fig. 1b) were analysed together for this study. Filled symbols 
indicate BPI, half-filled symbols indicate major depression (right 
half filled) and BPII (left half filled). Filled symbols with a blank 
upper right quarter indicate schizophrenia. Individuals labelled 
‘Psy’ have suffered episodes of psychosis. 
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consistencies with mendelian inheritance using PedCheck  [16] , 
and the occurrence of non-mendelian errors was tested with Sim-
Walk2 v2.9.1  [17, 18] . The quality-checked genotype data for the 
9 new families were combined with those from our previous study 
of 6 extended BPI families  [10] by calibrating all genotypes using 
a CEPH sample of known genotype (CEPH 1347-02). All analyses 
were carried out on the combined data set. Because the patterns 
of disease transmission did not support an X-chromosomal mode 
of inheritance in the Antioquian pedigrees, the X-chromosome 
was not analysed. The present study therefore represents an auto-
some-wide linkage scan.
 Data Analysis and Statistical Methods 
 We focused our ascertainment strategy on families segregat-
ing  BPI. However, several other psychiatric diagnoses segregate 
in these pedigrees, most notably major depression. We therefore 
analysed our data under 3 different diagnostic models. In a con-
servative model, only cases of BPI were considered affected (‘nar-
row model’). In the second model, cases of BPI, BPII and major 
depression were considered affected (‘broad model’). In a third 
model, the affection status was defined by the occurrence of psy-
chosis (‘psychosis model’). Because not all families included 2 or 
more individuals affected by psychosis, the data set for this last 
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 Fig. 1.  b Set of 6 Antioquian pedigrees genotyped in an initial 
linkage scan in the Antioquian population  [10] . Both sets of ped-
igrees (shown here and in fig. 1a) were analysed together for this 
study. Individuals marked with a cross were available for genotyp-
ing. Filled symbols indicate BPI, half-filled symbols indicate ma-
jor depression (right half filled) and BPII (left half filled). Filled 
symbols with a blank upper right quarter indicate schizophrenia. 
Individuals labelled ‘Psy’ have suffered episodes of psychosis. 
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model comprised only 11 pedigrees. For analyses under all 3 mod-
els, all remaining family members were considered to be of un-
known phenotype.
 Multipoint parametric heterogeneity LOD (HLOD) score and 
nonparametric linkage (NPL) analyses were performed using 
SimWalk2 v2.9.1  [17] . Due to the uncertainties involved in speci-
fying an inheritance model underlying the aetiologically complex 
phenotypes analysed here, NPL analysis was conducted for all 3 
phenotypic models. For the narrow (BPI) model only, we also car-
ried out parametric analyses in order to enable a direct compari-
son of the results from the present study to those from our previ-
ous study, which involved part of the families included here  [10] . 
Parametric linkage analysis was performed under both a domi-
nant and a recessive model. Analysis under the dominant model 
was carried out employing the same parameters used in our pre-
vious linkage scan; these parameters were estimated in previous 
studies of families from the Central Valley of Costa Rica  [10, 19] . 
The frequency of the disease allele was set at 0.003, the phenocopy 
rate at 0.01, and the penetrances for heterozygous and homozy-
gous carriers of the disease allele were set to 0.81 and 0.9, respec-
tively. Under the recessive model, the frequency of the disease 
allele was set to 0.1, the phenocopy rate to 0.01, and the penetrance 
for homozygous carriers of the disease allele was set to 0.80. These 
parameter values have been used in previous studies (e.g.  [20] ). In 
order to reduce the number of tests carried out and to facilitate 
comparison with our previous analysis of a subset of these fami-
lies, the model-based linkage analysis was performed only for the 
narrow phenotypic model. Marker allele frequencies for all anal-
yses were estimated from the complete pedigree data set using 
Mendel v8.0.1, correcting for relatedness between individuals 
 [21] . Three-digit genotypes were recoded to a 2-digit format, and 
data files converted to different formats, as required, using Mega2 
v4.0  [22] . All analyses used the Marshfield genetic map (http://
research.marshfieldclinic.org/genetics/home/index.asp).
 Results 
 Genotype data for 382 autosomal microsatellite mark-
ers were obtained for 75 samples from 9 pedigrees. Geno-
type data for a further 91 samples from 6 pedigrees from 
our previously published linkage study  [10] were available 
for the same set of markers. For 10 markers, the genotypes 
from both data sets could not be calibrated unambigu-
ously; these were excluded from further analyses (D1S498, 
D1S2836, D5S418, D6S262, D11S905, D13S159, D15S994, 
D17S798, D19S221, and D21S263). The overall data com-
pleteness was 94% across chromosomes and samples.
 The genome-wide results of the parametric and non-
parametric analyses are shown in  figures 2 and  3 , respec-
tively. The most noticeable results have been extracted 
into  table  1 (results for individual families are sum-
marised in  table 2 ).
 The most interesting study-wide signals were found on 
chromosome 7p21.1–p22.2, with a HLOD score of 2.80 for 
the recessive analysis under the narrow diagnostic model, 
and at marker D12S85 on chromosome 12q13.11, where 
NPL scores of 2.55 and 2.35 were observed in nonparamet-
ric analysis under narrow and broad diagnostic models, 
respectively. A HLOD score of 2.14 was observed on chro-
mosome 21q at marker D21S1914 in the dominant para-
metric  analysis  under   the   narrow   diagnostic   model. For 
this marker, a parametric LOD score of 3.21 was observed 
in family CO7, and a NPL score of 2.32 in  family CO14 
(see      table       2 ).       For       the       dominant       analysis,       HLOD scores 
 1 1.3 were also observed on chromosomes 13q and 1p.
 Nonparametric analysis under the narrow diagnostic 
model identified additional candidate regions on chro-
mosomes 1p31.1–p21.2, 1q31.1, 5q12.3, and 9p21.2. Chro-
mosome 1p was also highlighted by the parametric anal-
ysis (see above), and by the nonparametric analysis under 
the broad diagnostic model; results from all 3 analyses 
defined a common candidate region on chromosome 
1p31.1–p21.2. Candidate regions on chromosomes 1q31.1 
and 9p21.2 were also supported by the nonparametric 
analysis under the broad diagnostic model.
 For the psychosis phenotype, the highest NPL scores 
were obtained for chromosomes 2q24.3 and 16p12.1 (2.09 
and 2.05, respectively); NPL scores  6 1.3 were also identi-
fied on chromosomes 6q, 10q, and 12q. The signal on 
chromosome 12q was 34cM telomeric of the most sig-
nificant signal obtained under narrow and broad models.
 Discussion 
 We performed a whole-genome linkage scan in 15 ex-
tended pedigrees segregating severe BP from the popula-
tion isolate of Antioquia, Colombia. While we identified 
no signals at a genome-wide level of significance, we 
found suggestive evidence for a range of candidate re-
gions for BP, mood disorders in general, and psychosis. A 
lack of significant results at a genome-wide level has char-
acterised linkage studies of BP for the past decades, re-
flecting the challenges implicated in the mapping of sus-
ceptibility variants for complex psychiatric disease, and 
 Fig. 2. Results of the parametric linkage analysis under the nar-
row diagnostic model and near-dominant ( a ) and recessive ( b ) 
inheritance models. Multipoint HLOD scores (solid black line) 
and the estimated proportion of linked families (  ; dotted red 
line) are plotted against the cumulative genetic distance in Hal-
dane cM. Chromosomes are separated by dotted black lines. 
(For figures see next pages.)
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making the replication of results all the more important. 
Interestingly, and encouragingly, many of our results rep-
licate findings from previous studies, as discussed in de-
tail below.
 BP is a complex and heterogeneous condition, whose 
mode of inheritance does not easily conform to standard 
linkage analysis. The use of nonparametric methods pro-
vides a way of overcoming these difficulties, while the use 
of different diagnostic models can help explore the pos-
sible genetic overlap between BP, mood disorders and 
schizophrenia. Consequently, we performed NPL analy-
sis under 3 different diagnostic models: BPI only; BPI, 
BPII and major unipolar depression; and psychosis (i.e. 
‘narrow’, ‘broad’, and ‘psychosis models’, respectively). 
Additionally, parametric linkage analysis was used for 
the narrow diagnosis, using both a near-dominant and a 
recessive inheritance model. A similar combination of di-
agnostic definitions and genetic models has been previ-
ously used in a number of linkage studies of BP (e.g.  [20] ).
 There was a substantial overlap in the results obtained 
with the narrow and broad diagnostic models, as both 
analyses highlighted loci on chromosomes 1p13–31, 
1q25–31 and 12p11–q14. An overlap of linkage signals un-
der these 2 diagnostic models has been previously report-
ed  [23–28] . These observations suggest the existence of 
loci predisposing to mood disorders in general rather 
than to BP in particular, consistent with the observation 
of an increased rate of major depression in relatives of BP 
patients  [29] .
 The narrow diagnostic model (BPI) also produced 
some specific linkage signals on chromosomes 7p21–22, 
5q12, 13q33 and 21q21–22, although results differed 
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 Fig. 3. Results of the NPL analysis under narrow ( a ), broad ( b ) and psychosis models ( c ). NPL scores are plotted 
against the cumulative genetic distance in Haldane cM. Chromosomes are separated by dotted lines. 
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somewhat between parametric and nonparametric anal-
yses (see  table  1 ). The loci on chromosomes 7p21–22, 
13q33 and 21q21–22 were highlighted by the parametric 
analysis, possibly implicating that segregation patterns at 
these loci were broadly consistent with the model used for 
analysis. Segregation on chromosome 7p21–22 may hence 
best fit the recessive model, while segregation of loci on 
chromosomes 13q33 and 21q21–22 may best fit the near-
dominant mode of inheritance. It is possible that these 
regions were not consistently picked up by the nonpara-
metric analysis because of its reduced power (although 
NPL analysis did produce a p value of 0.0212 for the chro-
mosome 7 region under the broad phenotypic model).
 Results under the psychosis phenotype implicated dif-
ferent regions from those suggested by the 2 other diag-
nostic models (chromosomes 2q24–31, 10q21 and 16p12). 
There are very few published analyses of the psychosis 
phenotype in bipolar pedigrees; available results are con-
sistent with our findings in that they implicate regions 
different from those linked to BP as such  [30, 31] , suggest-
ing that there are genetic loci conferring susceptibility to 
psychosis independent of affective disorders  per se . The 
concept of a genetic predisposition to psychosis is in line 
with evidence for a shared genetic susceptibility between 
BP and schizophrenia  [32, 33] .
 Several of the loci identified here have been reported 
in previous studies of BP. Both the 13q33 and 21q21–22 
regions have repeatedly been implicated in susceptibility 
to BP  [23, 28, 34–37] . The region on 21q21 was one of the 
best-supported loci in our previous linkage scan  [10] , and 
the present study provides further support for this region. 
Interestingly, most of the studies showing evidence for a 
locus on chromosome 21q also used a narrow diagnostic 
model similar to the one used here  [23, 28, 35] . Lin and 
colleagues  [38] also reported linkage of chromosome 
21q22 for early-onset BP, a subtype of the disorder associ-
Table 1.  Chromosomal regions suggestive of linkage (LOD or NPL ≥1.3) in the collection of 15 Antioquian BP pedigrees
Chro-
mosome
Diagnostic
model
Inheritance
model
Maximum
HLOD
Proportion of
linked families, 
Marker interval Chromosomal
region
Position
Mb
Parametric analysis
1 narrow dominant 1.32 0.35 D1S2841–D1S2868 1p31.1–p22.1 79.49–93.35
1 narrow recessive 1.47 0.6 D1S196–D1S218 1q24.2–q25.1 167.60–174.50
7 narrow recessive 2.80 0.65 D7S517–D7S507 7p22.2–p21.1 4.50–17.60
13 narrow dominant 1.46 0.3 D13S158–D13S173 13q33.1–q33.3 103.98–107.81
21 narrow dominant 2.14 0.15 D21S1256–D21S1252 21q21.1–q22.13 19.32–37.83
Chro-
mosome
Diagnostic
model
Inheritance
model
Maximum
NPL
p value Marker interval Chromosomal
region
Position
Mb
Nonparametric analysis
1 narrow model-free 2.13 0.0074 D1S207–D1S206 1p31.1–p21.2 82.54–101.69
1 broad model-free 2.22 0.0060 D1S207–D1S206 1p31.1–p21.2 82.54–101.69
1 narrow model-free 1.71 0.0194 D1S238 1q31.1 188.15
1 broad model-free 1.68 0.0207 D1S238 1q31.1 188.15
2 psychosis model-free 2.09 0.0081 D2S2330 2q24.3 166.70
5 narrow model-free 1.85 0.0142 D5S647 5q12.3 66.25
6 broad model-free 1.54 0.0286 D6S276–D6S1610 6p22.2–p21.2 24.19–39.26
6 psychosis model-free 1.44 0.0367 D6S441 6q25.2 153.81
7 broad model-free 1.67 0.0212 D7S507 7p21.1 17.60
9 narrow model-free 1.61 0.0246 D9S161 9p21.2 27.63
9 broad model-free 1.50 0.0319 D9S161 9p21.2 27.63
10 psychosis model-free 1.36 0.0434 D10S1652 10q21.2 64.41
12 narrow model-free 2.55 0.0028 D12S345–D12S368 12p11.21–q13.13 32.32–52.63
12 broad model-free 2.35 0.0044 D12S345–D12S83 12p11.21–q14.1 32.32–60.89
12 psychosis model-free 1.39 0.0403 D12S351 12q21.33 91.90
16 psychosis model-free 2.05 0.0089 D16S3068 16p12.1 25.56
Physical marker positions are from the February 2009 assembly of the UCSC genome browser (http://genome.ucsc.edu).
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ated with increased severity of clinical symptoms  [39] . 
Interestingly, the 13q33 region harbours the  DAOA  gene 
which has been found to be associated with both BP and 
schizophrenia  [40–44] .
 The loci on 1p13–31 and 1q25–31 implicated here have 
also both been reported to be involved in BP susceptibil-
ity  [23, 45–50] . The chromosome 1p13–31 region had 
been highlighted by our initial genome scan  [10] , and the 
present study has further strengthened this signal. The 
locus on the long arm of chromosome 1 has frequently 
been linked to schizophrenia  [33, 51–54] . This region in-
cludes the genes encoding the regulator of G signalling 
protein,  RGS4 , and the nitric oxide synthase 1 (neuronal) 
adaptor protein,  NOS1AP ,  which have both been associ-
ated with BP or schizophrenia  [55–59] . Interestingly, 
NOS1AP expression has been found to be increased in the 
prefrontal cortex of bipolar subjects  [60] .
 The strongest support for linkage in our study was ob-
served for regions on chromosome 7p21.1–p22.2 (under 
the narrow affection model and assuming recessive in-
heritance), and 12q13 (under both narrow and broad af-
fection models).
 Evidence of linkage of BP to the chromosome 7p21 re-
gion has been reported in a set of 16 extended Portuguese 
Island pedigrees  [61] . The replication of this finding in 
the Colombian families is of interest because both popu-
lations share ancestral contributions from the Iberian 
Peninsula.
 The chromosome 12q13 region has been implicated in 
a study of French Canadian BP pedigrees. Like the pres-
ent study, the signal from the Canadian pedigrees was 
obtained using a broad diagnostic model including BPI, 
BPII, schizoaffective disorder and recurrent unipolar de-
pression  [34] . However, the strongest support for linkage 
in the Canadian families appears to be in a region telo-
meric to the locus described here. An interesting candi-
date gene in the region identified here is  Timeless . This 
gene plays a crucial role in the regulation of circadian 
rhythms  [62] , the dysfunction of which is a widespread 
phenomenon in BP  [63] .
 Amongst the regions implicated under the psychosis 
model, both chromosomes 2q24 and 16p12 have previ-
ously been linked to psychiatric disease. The 2q24 region 
has been implicated in both BP and schizophrenia  [53, 64, 
65] , and the chromosome 16p12 region has been impli-
cated in severe psychotic BP  [31] . Interestingly, the most 
significant signal in the WTCCC BP genome-wide asso-
ciation study was for a SNP in the 16p12 region  [6] . This 
Table 2.  Chromosomal regions suggestive of linkage (LOD ≥2 or NPL ≥2) in individual families
Chro-
mosome
Diagnostic
model
Inheritance
model
Maximum
LOD
Marker interval Chromosomal
region
Position
Mb
Pedigree
ID
Parametric analysis
1 narrow dominant 2.06 D1S2890–D1S230 1p32.2–p31.3 57.87–62.60 CO27
3 narrow dominant 2.57 D3S1565–D3S1601 3q26.31–q28 173.48–191.68 CO7
11 narrow dominant 2.19 D11S905–D11S987 11p12–q13.2 40.97–67.89 CO1
15 narrow dominant 2.46 D15S127–D15S120 15q26.1–15tel 91.40–99.59 CO18
21 narrow dominant 3.21 D21S1256–D21S1252 21q21.1–q22.13 19.32–37.83 CO7
Chro-
mosome
Diagnostic 
Model
Inheritance
model
Maximum
NPL (p value)
Marker interval Chromosomal
region
Position
Mb
Pedigree
ID
Nonparametric analysis
1 broad model-free 2.00 (0.0101) D1S207 1p31.1 82.54 CO27
2 broad model-free 2.23 (0.0059) D2S117–D2S325 2q32.3–q33.3 195.62–208.27 CO23
3 narrow model-free 2.32 (0.0048) D3S1580 3q28 188.54 CO7
4 psychosis model-free 2.30 (0.0051) D4S424 4q31.21 142.20 CO14
16 narrow model-free 2.49 (0.0032) D16S3046–D16S3068 16p12.2–12.1 20.89–25.56 CO7
16 psychosis model-free 2.40 (0.0040) D16S3046 16p12.2 20.89 CO7
16 broad model-free 2.12 (0.0075) D16S3068 16p12.1 25.56 CO7
21 narrow model-free 2.32 (0.0048) D21S1914 21q21.2 25.62 CO14
Physical marker positions are from the February 2009 assembly of the UCSC genome browser (http://genome.ucsc.edu).
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region harbours several interesting candidate genes, in-
cluding  DCTN5 , whose product appears to interact with 
that of  DISC1  (Disrupted in Schizophrenia 1), a gene re-
peatedly linked to schizophrenia  [66, 67] .
 In this expanded pedigree sample we failed to find fur-
ther linkage support for the 5q31–34 region implicated by 
a subset of the families analysed previously  [10] . A pos-
sible explanation is interfamily heterogeneity. In particu-
lar the two largest families examined here (CO1 and 
CO28) stem from an isolated village, which could repre-
sent a subisolate within Antioquia. Neither of these two 
families provides support for a locus on chromosome 
5q31–34, and due to their size, these two pedigrees have 
a strong impact on the total LOD-scores calculated. For 
a complex disorder like BP, genetic heterogeneity is not 
unlikely even within a population isolate.
 Such difficulties highlight the need to readjust how 
results from linkage studies should be interpreted. Most 
individual studies might not have sufficient power to de-
tect susceptibility loci for psychiatric disease on their 
own, and replication studies and meta-analyses are es-
sential to evaluate the true significance of linkage find-
ings. In this respect, it is interesting that regions high-
lighted by meta-analyses of genome-wide linkage studies 
of BP often do not coincide with the most significant sig-
nals of the individual studies included  [47, 68, 69] . Results 
from an individual study might therefore represent rela-
tively larger genetic effects of importance only for a spe-
cific family or population. On the other hand, individu-
ally weaker signals could show greater consistency across 
studies, hence only reaching statistical significance 
through meta-analyses. Family studies have contributed, 
and continue to contribute, important information to the 
emerging picture of genetic predisposition to BP. The 
present study, which has provided further supporting ev-
idence for a range of previously reported loci, but in which 
we have also identified a possible novel locus on chromo-
some 12q13, adds to this picture.
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